Sector: Agricultural Food & other Products - Fast Moving Consumer Goods
BSE Code: 537291
NSE Symbol: NATHBIOGEN
ISIN: INE448G01010
Nath Bio-Genes Q3 FY26: Revenue Soars 79% 📈 Seed Sales Show Strong Growth • Q3 FY26 total revenue: ₹660 million (79% YoY increase) • 9MFY26 total revenue: ₹3,859 million (23% YoY growth) • Cotton seed sales value: up 25.26% YoY • Maize seed sales value: surged 141.98% YoY • Vegetable seeds segmen…
📄 Nath Bio-Genes Issues Duplicate Share Certificate • Duplicate share certificate issued for lost/misplaced original certificate • Affected shareholder has folio number 0007420 • Original certificate number was 7520 • Processed by Bigshare Services Private Limited, the company's Registrar and Sha…
Nath Bio-Genes Q3 2025: Standalone Profit Up 172% 📊 • Standalone Q3 2025 revenue: ₹6,596.11 lakhs • Nine-month standalone revenue: ₹38,590.36 lakhs • Standalone Q3 2025 net profit: ₹723.08 lakhs (vs ₹265.50 lakhs in Q3 2024) • Nine-month standalone net profit: ₹4,463.77 lakhs (vs ₹3,943.11 lakhs …
📊 Nath Bio-Genes Q3 & 9M Results Meeting Scheduled for Jan 31, 2026 • Board meeting scheduled for January 31, 2026 to approve unaudited financial results • Results cover Q3 and nine months ended December 31, 2025 • Includes both standalone and consolidated financial figures • Trading window close…
🔍 Tapovan Paper Acquires 0.40% Stake in Nath Bio-Genes – Key Details - Tapovan Paper and Board Mills acquires 75,645 equity shares (0.40% stake) in Nath Bio-Genes (India) Ltd from Paresh Farms and Prabha Farms. - Acquisition part of a Scheme of Arrangement approved by NCLT Mumbai on November 26, …
Nath Bio-Genes Targets 15-20% Growth by FY '27 🌱 | Key Financial & R&D Updates - Revenue growth target: 15-20% by FY '27, aiming for ₹500 crores top-line. - H1 FY '26 revenue: ₹3,199M (15.9% Y-o-Y growth). - Gross profit up 21.3% Y-o-Y; PAT at ₹424M (15.3% growth). - Cotton business: 6% volume & …
Nath Bio-Genes Q2 FY26 Results: Strong Revenue & Profit Growth 📈 - Q2 FY26 Total Revenue: INR 398 Mn (up 23.5% YoY) - H1 FY26 Revenue: INR 3,199 Mn (up 15.9% YoY) - Q2 Gross Profit: INR 269 Mn (up 36.4% YoY), Gross Margin at 68% (vs. 60% YoY) - Q2 PAT: INR 42 Mn (up 45.4% YoY), EPS: INR 2.16 (up …
Nath Bio-Genes Q2 2025 Results: Revenue Surges, Profit Trends Mixed 📊 - Standalone revenue: ₹39,770.70 lakhs (Q2 2025) vs ₹26,017.18 lakhs (Q2 2024) – 53% YoY growth - Standalone net profit: ₹420.09 lakhs (Q2 2025) vs ₹382.06 lakhs (Q2 2024) – 10% YoY growth - Consolidated revenue: ₹43,849.60 lak…
📅 Nath Bio-Genes (I) Ltd. Q2 & H1 FY26 Earnings Call – Join the Discussion! - Earnings Conference Call on Friday, 14th November 2025 at 12:30 PM IST. - Discussion will cover Q2 & H1 FY26 earnings. - Key participants include Mr. Satish Kagliwal (MD), Dr. Devinder Khurana (EVP), Mr. Amol Gupta (CFO…
📅 Nath Bio-Genes Q2 & H1 FY2026 Results: Board Meeting on Nov 13 - Board meeting scheduled for 13th November 2025 to approve unaudited financial results for the quarter and half year ended 30th September 2025. - Meeting will consider standalone and consolidated financial results. - Trading window…
Nath Bio-Genes Q1 FY26 Results: Strong Growth Across Segments 📈 - Q1 FY26 total revenue: INR 2,802 Mn (up 14.9% YoY). - Gross profit: INR 1,438 Mn (51% margin), up from INR 1,210 Mn (49.6%) in Q1 FY25. - EBITDA: INR 389 Mn (14% margin), a 5% YoY increase. - PAT: INR 361 Mn, up 6.7% YoY. - EPS: IN…
Nath BioGenes Reports Steady Growth in Q2 2025 📈 - Standalone revenue for Q2 2025: ₹28,017.18 lakhs (14.89% YoY growth) - Standalone net profit for Q2 2025: ₹3,820.60 lakhs (12.75% YoY growth) - Consolidated revenue for Q2 2025: ₹28,370.01 lakhs (16.33% YoY growth) - Consolidated net profit for Q…
Nath Bio-Genes Director Resigns 📋 - Ms. Shipra Agrawal resigned as Additional Director (Independent) of Nath Bio-Genes (India) Ltd. - Effective resignation date: July 3, 2025. - Reason for resignation: Pre-occupation and personal reasons. - She did not hold any directorship in other listed compan…